Significant Milestone is Expected to Advance Company Mission to Fix Fundamental Flaws in the Current Internet Economic Model London, UK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc. (OTC PINK: BBLR) ("Bubblr" or the "Company"), an ethical technology company focused on the development and commercialization of mobile-first technologies, today… Read More..
Company Pursuing Development of PAX-101 as Treatment for Autism Spectrum Disorder and Other Neurodevelopmental Conditions WOODCLIFF LAKE, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- PaxMedica, Inc. ("PaxMedica" or the “Company”), a biopharmaceutical company focused on the development and commercialization of innovative treatments for unmet needs in neurodevelopmental… Read More..
PRINCETON, N.J., Feb. 1, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Hong Kong Registrar of Patents has granted a patent for the application… Read More..